fda warning compounded semaglutide safety 2024 2025 Is Safe? FDA issued 25 warning letters

Unlike earlier GLP-1 receptor agonists like semaglutide (Ozempic/Wegovy) that target a single hormone pathway, or tirzepatide (Mounjaro/Zepbound) that targets two, retatrutide activates three distinct metabolic receptors : GIP, GLP-1, and glucagon

Common side effects include: Nausea, Vomiting, Diarrhea, Stomach pain, Constipation

Im human, I like tasty things

For people with type 2 diabetes or metabolic syndrome, these changes can be clinically significant

If you're using such a product, the formulator has presumably addressed compatibility concerns

A favorite for clients post-surgery or with old injuries flaring up after intense workouts